Nancy Stagliano serves as Executive at Pandion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Nancy Stagliano has executed 4 insider transactions totaling $18.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 1, 2021 involved transacting 73,067 shares valued at $4.4M.
Nancy Stagliano currently holds 1,000 shares of Pandion Therapeutics, Inc. (PAND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy Stagliano has been a net buyer of PAND stock. They have purchased $18.0K and sold $0 worth of shares.
Nancy Stagliano's most recent insider trade was on Apr 1, 2021, when they sold 73,067 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted
| $60.00 |
| Discretionary |
| Jul 21, 2020 | PAND | $18.0K | Purchase | 1,000 | $18.00 | Discretionary |
| Jul 21, 2020 | PAND | $0 | Conversion | 15,004 | $N/A | Discretionary |